Comparison of Ability of pCLE and WLE for Diagnosis and Cancer Tissue Acquisition in Advanced Gastric Cancer After Chemotherapy Status
Advanced Gastric Cancer, Neoadjuvant Chemotherapy, Palliative Chemotherapy
About this trial
This is an interventional diagnostic trial for Advanced Gastric Cancer focused on measuring pCLE, confocal, Advanced gastric cancer, chemotherapy
Eligibility Criteria
Inclusion Criteria:
A. Older than 20 years old and younger than 80 years old B. Patients who completed neoadjuvant chemotherapy with AGC C. Patients who underwent palliative chemotherapy with AGC
Exclusion Criteria:
A. Previous subtotal gastrectomy B. Previous EMR/ESD history C. Significant cardiopulmonary disease D. Active hepatitis or severe hepatic dysfunction E. Severe renal dysfunction F. Severe bone marrow dysfunction G. Severe neurologic or psychotic disorder H. Pregnancy or breast feeding
Sites / Locations
- Yonsei university of medical centerRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Target biopsy under pCLE
Random biopsy at cancer lesion under WLE
(Cellvisio® with confocal minoprobe™, Mauna Kea Technologies, France)
WLE (GIF-HQ290, Olympus, Japan) group